# K130411: 740 Select

- Pathway: 510(k) (Traditional)
- Applicant: Cas Medical Systems, Inc.
- Decided: May 29, 2013 after 99 days
- Product code: MWI (Monitor, Physiological, Patient (Without Arrhythmia Detection Or Alarms))
- Device class: 2
- Regulation: 21 CFR 870.2300
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 7 generations back to K962603 (1997). 22 ancestors in all.
6 later devices descend from it; 3 cite it directly.
0 of 29 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K033048: Cas 740 Series Monitor, Models 740-1, 740M-1, 740-2MS, 740M-2MS, 740-2NL, 740M-2NL, 740-2NN, 740M-2NN, 740-3MS, 740M-3MS, Cas Medical Systems, Inc. (2004) Summary page 2.

## Most influential descendants
- K171751: SmartLinx Vitals Plus NIBP Module, SmartLinx Vitals Plus License for Spot Monitoring Mode, SmartLinx Vitals Plus Alarm Hub, SmartLinx Vitals Plus License for Advanced Monitoring Mode, Covidien FILAC 3000 - Temperature Module (2017), 2 descendants of its own
- K140430: 740 Select (2014), 1 descendant of its own
- K200160: 740 SafeSAT (2021), 0 descendants of its own
- K190468: Nihon Kohden SVM-7200 Series Vital Signs Monitor (2019), 0 descendants of its own
- K180734: SmartLinx Vitals Plus Patient Monitoring System (2018), 0 descendants of its own

## Indications for use
The 740 SELECT is indicated for use as a bedside, portable device for use by health care professionals, clinicians and medically qualified personnel for spot checking, continuous monitoring and recording of adult, pediatric and neonatal patients. The Monitor features world class technology to facilitate the monitoring of non-invasive blood pressure, pulse rate, functional arterial oxygen saturation (SpO2) and body temperature in a variety of clinical environments.

Source page: https://510kreport.com/device/K130411
Methodology: https://510kreport.com/methodology